Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X2AT
|
||||
| Former ID |
DIB012018
|
||||
| Drug Name |
Rhopressa
|
||||
| Indication | Glaucoma [ICD9: 365; ICD10:H40-H42] | Phase 2 | [533091] | ||
| Company |
Aerie pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | [533091] | |
| Rho associated protein kinase | Target Info | Modulator | [533091] | ||
| PANTHER Pathway | Adrenaline and noradrenaline biosynthesis | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

